Tag - 2015

17
Nov

HealthEdge Announces Jon Boumstein and Terry Conrad Join as Operating Partners

HealthEdge Announces Jon Boumstein and Terry Conrad Join as Operating Partners   TAMPA, FLORIDA – November 17, 2015 – HealthEdge Investment Partners, LLC (“HealthEdge”), a Tampa, FL healthcare focused investment firm, announced today that Jon Boumstein and Terry Conrad have joined the team as Operating Partners. Mr. Boumstein currently serves as President and CEO of …

31
Aug

HealthEdge Announces Exit of Scar Away to Perrigo

HealthEdge Announces Exit of Scar Away to Perrigo   TAMPA, FLORIDA – August 31, 2015 – HealthEdge Investment Partners, LLC (“HealthEdge”), a Tampa, FL healthcare focused investment firm, announced today that Fund I portfolio company Enaltus has sold ScarAway® (“ScarAway”) to Perrigo Company plc (“Perrigo”) (NYSE: PRGO; TASE). ScarAway is a leading U.S. OTC scar …

30
Jul

HealthEdge Completes Investment in Medicine‐On‐Time

HealthEdge Completes Investment in Medicine‐On‐Time TAMPA, FLORIDA – July 30, 2015 – HealthEdge Investment Partners announced today that together with Brook Venture Partners it has completed an investment in Multi‐Comp, Inc. d/b/a Medicine‐On‐ Time (“MOT” or the “Company”), its seventh portfolio company in HealthEdge Investment Fund II. Medicine‐On‐Time is a leading provider of medication and …

4
Jun

HealthEdge Completes Investment in Santus

HealthEdge Completes Investment in Santus TAMPA, FLORIDA – June 4, 2015 – HealthEdge Investment Partners (“HealthEdge”) announced that Santus, LLC (“Santus” or the “Company”), owned jointly with Ambassador Enterprises (“Ambassador”), has acquired substantially all the healthcare assets from Summit Industries, Inc. (“Summit”), primarily consisting of the Lantiseptic® and Boroleum® brands (the “brands”). Santus was formed …

28
Apr

HealthEdge Completes Investment in Medical Neurogenetics, Appoints Interim CEO

HealthEdge Completes Investment in Medical Neurogenetics, Appoints Interim CEO TAMPA, FLORIDA – April 28, 2015 – HealthEdge Investment Partners announced today that it has completed an investment in Medical Neurogenetics, LLC, an Atlanta, Georgia‐based esoteric lab that represents the fifth portfolio company in HealthEdge Investment Fund II. HealthEdge is also pleased to announce the appointment …